Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 318

1.

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.

Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, Burnier M, Chatellier G, Durand Zaleski I, Grassi G, Joner M, Kandzari DE, Kirtane A, Kjeldsen SE, Lobo MD, Lüscher TF, McEvoy JW, Parati G, Rossignol P, Ruilope L, Schlaich MP, Shahzad A, Sharif F, Sharp ASP, Sievert H, Volpe M, Weber MA, Schmieder RE, Tsioufis C, Wijns W.

Eur Heart J. 2020 Mar 25. pii: ehaa121. doi: 10.1093/eurheartj/ehaa121. [Epub ahead of print] No abstract available.

PMID:
32211888
2.

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection.

Herat LY, Magno AL, Rudnicka C, Hricova J, Carnagarin R, Ward NC, Arcambal A, Kiuchi MG, Head GA, Schlaich MP, Matthews VB.

JACC Basic Transl Sci. 2020 Jan 29;5(2):169-179. doi: 10.1016/j.jacbts.2019.11.007. eCollection 2020 Feb.

3.

Shaping the future of renal denervation-the relevance of sham-controlled randomized trials and recent meta-analyses.

Kiuchi MG, Ho JK, Lugo Gavidia LM, Schlaich MP.

Cardiovasc Diagn Ther. 2019 Dec;9(6):601-606. doi: 10.21037/cdt.2019.07.03. No abstract available.

4.

Does sympathetic hyperactivity adversely impact on the effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure?

Kiuchi MG, Chen S, Carnagarin R, Villacorta H, Schlaich MP.

Europace. 2020 Feb 1;22(2):331. doi: 10.1093/europace/euz298. No abstract available.

PMID:
32031229
5.

The role of afferent renal denervation in renovascular hypertension-another brick in the wall.

Kiuchi MG, Chen S, Carnagarin R, Schlaich MP.

Pflugers Arch. 2020 Mar;472(3):323-324. doi: 10.1007/s00424-020-02354-9. Epub 2020 Feb 5. No abstract available.

PMID:
32025813
6.

Sympathetic Activation in Hypertensive Chronic Kidney Disease - A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Kiuchi MG, Ho JK, Nolde JM, Gavidia LML, Carnagarin R, Matthews VB, Schlaich MP.

Front Physiol. 2020 Jan 14;10:1546. doi: 10.3389/fphys.2019.01546. eCollection 2019. Review.

7.

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy - a perspective.

Kiuchi MG, Carnagarin R, Matthews VB, Schlaich MP.

Postepy Kardiol Interwencyjnej. 2019;15(4):503-504. doi: 10.5114/aic.2019.90231. Epub 2019 Dec 8. No abstract available.

8.

Shades of grey: a matter relevant to sympathetic activity and blood pressure control?

Schlaich MP, Kiuchi MG, Carnagarin R, Grassi G.

J Hypertens. 2020 Feb;38(2):206-207. doi: 10.1097/HJH.0000000000002325. No abstract available.

PMID:
31913947
9.

Does sympathetic hyperactivity adversely impact on the effect of pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation?

Kiuchi MG, Chen S, Carnagarin R, Matthews VB, Schlaich MP.

Europace. 2020 Mar 1;22(3):506. doi: 10.1093/europace/euz316. No abstract available.

PMID:
31793998
10.

Ambulatory blood pressure monitoring and morning surge in blood pressure in adult black and white South Africans.

Lambert GW, Head GA, Chen WS, Hamer M, Malan NT, Quinn S, Schlaich MP, Malan L.

J Clin Hypertens (Greenwich). 2020 Jan;22(1):21-28. doi: 10.1111/jch.13740. Epub 2019 Nov 25.

11.

Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient.

Kotsis V, Jordan J, Stabouli S, Antza C, Micic D, Jelaković B, Schlaich MP, Nilsson PM, Kreutz R, Mancia G, Tsioufis K, Grassi G.

J Hypertens. 2020 Mar;38(3):377-386. doi: 10.1097/HJH.0000000000002279.

PMID:
31764586
12.

Android Fat Deposition and Its Association With Cardiovascular Risk Factors in Overweight Young Males.

Sari CI, Eikelis N, Head GA, Schlaich M, Meikle P, Lambert G, Lambert E.

Front Physiol. 2019 Sep 18;10:1162. doi: 10.3389/fphys.2019.01162. eCollection 2019.

13.

Renal denervation for treating congenital long QT syndrome: shortening the QT interval or modulating sympathetic tone?

Kiuchi MG, Chen S, Carnagarin R, Matthews VB, Schlaich MP.

Europace. 2019 Nov 1;21(11):1755-1756. doi: 10.1093/europace/euz251. No abstract available.

PMID:
31603504
14.

The Schlager mouse as a model of altered retinal phenotype.

Herat LY, Magno AL, Kiuchi MG, Jackson KL, Carnagarin R, Head GA, Schlaich MP, Matthews VB.

Neural Regen Res. 2020 Mar;15(3):512-518. doi: 10.4103/1673-5374.266069.

15.

New Molecules for Treating Resistant Hypertension: a Clinical Perspective.

Azzam O, Kiuchi MG, Ho JK, Matthews VB, Gavidia LML, Nolde JM, Carnagarin R, Schlaich MP.

Curr Hypertens Rep. 2019 Sep 10;21(10):80. doi: 10.1007/s11906-019-0978-z. Review.

PMID:
31506798
16.

Diuretics and skin cancer: should a common prescription come with advice to avoid sun exposure?

Schlaich MP, Nolde J, Carnagarin R, Kiuchi MG.

J Hypertens. 2019 Oct;37(10):1961-1962. doi: 10.1097/HJH.0000000000002174. No abstract available.

PMID:
31464861
17.

Multivariable Analysis of Patients With Severe Persistent Postprocedural Hypotension After Carotid Artery Stenting.

Oshin O, Varcoe R, Wong J, Burrows S, Altaf N, Schlaich M, Weerasooriya R, Gray W, Deloose K, Baumgartner I, Mwipatayi BP.

J Endovasc Ther. 2019 Dec;26(6):759-767. doi: 10.1177/1526602819869929. Epub 2019 Aug 21.

PMID:
31431153
18.

Effects of sympathetic modulation in metabolic disease.

Carnagarin R, Lambert GW, Kiuchi MG, Nolde JM, Matthews VB, Eikelis N, Lambert EA, Schlaich MP.

Ann N Y Acad Sci. 2019 Oct;1454(1):80-89. doi: 10.1111/nyas.14217. Epub 2019 Aug 19. Review.

PMID:
31424101
19.

New insights about post-exercise albuminuria in hypertensive patients.

Kiuchi MG, Chen S, Carnagarin R, Schlaich MP.

J Clin Hypertens (Greenwich). 2019 Aug;21(8):1180-1182. doi: 10.1111/jch.13632. Epub 2019 Jul 8. No abstract available.

20.

Sympathetic activity in obesity: a brief review of methods and supportive data.

Lambert GW, Schlaich MP, Eikelis N, Lambert EA.

Ann N Y Acad Sci. 2019 Oct;1454(1):56-67. doi: 10.1111/nyas.14140. Epub 2019 Jul 3. Review.

PMID:
31268175

Supplemental Content

Loading ...
Support Center